GlassScriptPhysician profile
Laurence J Karns
NPI 1871592584
$1,457.35
in general payments reported to CMS, 2019-2025
18 companies · $546 in 2025
The $546 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $143 · 2023: $273 · 2024: $316 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $435.60 | 2022-2025 | Rocklatan, Hydrus Microstent, Argos |
| Ivantis, INC | $180.23 | 2021 | |
| Mallinckrodt Hospital Products INC. | $135.26 | 2025 | Acthar |
| Biotissue Holdings INC. | $122.83 | 2024-2025 | |
| Oyster Point Pharma, INC. | $81.33 | 2022-2024 | Tyrvaya |
| Amgen INC. | $74.68 | 2024-2025 | Tepezza |
| Dompe US, INC. | $68.76 | 2024-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $67.89 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $64.92 | 2023-2025 | Miebo, Zenlens, Revive |
| Tarsus Pharmaceuticals, INC. | $42.72 | 2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $38.76 | 2023 | Acuvue |
| Sight Sciences, INC. | $30.49 | 2024 | Omni Surgical System |
| Horizon Therapeutics Plc | $24.92 | 2022 | |
| Abbvie INC. | $24.54 | 2025 | |
| Ocular Therapeutix, INC. | $19.43 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $16.18 | 2023 | Tecnis Iol |
| Apellis Pharmaceuticals, INC. | $14.60 | 2025 | Syfovre |
| New World Medical,INC. | $14.21 | 2025 | Streamline, Via360, Clearpath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Karns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.